You are on page 1of 3

Clostridium Difficile Infections (Clostridium Difficile

Associated Disease) Global Clinical Trials Review,


H2, 2015 Now Available at iData Insights
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2015
Summary GlobalData's clinical trial report, Clostridium Difficile Infections (Clostridium Difficile Associated Disease)
Global Clinical Trials Review, H2, 2015" provides an overview of Clostridium Difficile Infections (Clostridium Difficile
Associated Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on
Clostridium Difficile Infections (Clostridium Difficile Associated Disease). Report includes an overview of trial numbers
and their average enrollment in top countries conducted across the globe. The report offers coverage of disease
clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports
are generated using Global Data s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are
collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and
helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report
may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The
report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical
trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report
reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The
report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for
unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for
the past three months *Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with
regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and
cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in
interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional
and country level *Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=124168/clostridium-difficile-infections-clostridium-difficile-associated-disease-global-clinical-trialsreview-h2-2015
To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=124168/clostridium-difficile-infections-clostridium-difficile-associated-disease-global-clinical-trialsreview-h2-2015
Table of Contents
Table of Contents
2 List of Tables
3 List of Figures
4 Report Guidance
6 Clinical Trials by Region
7 Clinical Trials and Average Enrollment by Country
8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific

10 Top Five Countries Contributing to Clinical Trials in Europe


11 Top Countries Contributing to Clinical Trials in North America
12 Top Countries Contributing to Clinical Trials in Middle East and Africa
13 Top Five Countries Contributing to Clinical Trials in Central and South America
14 Clinical Trials by G7 Countries: Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated
Disease) to Infectious Disease Clinical Trials
15 Clinical Trials by Phase in G7 Countries
16 Clinical Trials in G7 Countries by Trial Status
17 Clinical Trials by E7 Countries: Proportion of Clostridium Difficile Infections (Clostridium Difficile Associated
Disease) to Infectious Disease Clinical Trials 18 Clinical Trials by Phase in E7 Countries
19 Clinical Trials in E7 Countries by Trial Status
20 Clinical Trials by Phase
21 In Progress Trials by Phase
22 Clinical Trials by Trial Status
23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type
26 Prominent Sponsors
27 Top Companies Participating in Clostridium Difficile Infections (Clostridium Difficile Associated Disease)
Therapeutics Clinical Trials
28 Prominent Drugs
29 Latest Clinical Trials News on Clostridium Difficile Infections (Clostridium Difficile Associated Disease)
30 Sep 28, 2015: Synthetic Biologics Initiates SYN-004 Phase 2b Proof-of-Concept Clinical Trial 30 Sep 21, 2015:
Synthetic Biologics Reports First Analysis Demonstrating SYN-004's Ability to Protect the Microbiome from Damage
Caused by IV Antibiotics in a Humanized Pig Model 30 Sep 20, 2015: Pivotal Phase 3 Studies of Bezlotoxumab,
Merck s Investigational Antitoxin to Prevent Clostridium Difficile Infection Recurrence, Met Primary Endpoint
31 Sep 18, 2015: Summit Therapeutics Presents New Positive Preclinical Data on Novel C. difficile Antibiotic
SMT19969 at ICAAC 2015
32 Sep 10, 2015: Summit Therapeutics Completes Targeted Enrolment for SMT19969 Phase 2 Trial for C. difficile
Infection
33 Jul 28, 2015: Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critical Animal Study
33 Jul 21, 2015: MGB Biopharma commences Phase I clinical trial with oral formulation of MGB-BP-3 for the
treatment of multi-resistant Clostridium Difficile infections
34 Clinical Trial Profile Snapshots
35 Appendix
134 Abbreviations
134 Definitions
134 Research Methodology 135 Secondary Research
135 About GlobalData 136 Contact Us 136 Disclaimer
137 Source

Read
More
@ http://www.idatainsights.com/reports-landing-page.php?id=124168/clostridium-difficile-infectionsclostridium-difficile-associated-disease-global-clinical-trials-review-h2-2015
About Us:
iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research
information aggregator and marketing research consulting firm. We conduct both primary and secondary research.
Our work does not end with research it is also involved in distributing reports for different companies . We provide
actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be
a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that
will make a difference to their bottom line.

Contact Us:
iData Insights
Tel: 1-866-237-2965
Web: http://www.idatainsights.com
Email: info@idatainsights.com

About iData Insights


We work around the clock until our clients are completely satisfied with their promised results. It is our mission to
provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our
promise to provide results that are essential to the success of your company. We believe that by doing so, we will
earn the trust of our clients for future projects.